Dyanavel XR 2.5 mg/mL
amphetamine · SUSPENSION, EXTENDED RELEASE · NextWave Pharmaceuticals, Inc
Dyanavel XR is an extended-release liquid suspension of amphetamine used to treat attention-deficit/hyperactivity disorder (ADHD) in patients who can take oral medication. As a central nervous system stimulant, it works by increasing attention and decreasing impulsivity and hyperactivity in people with ADHD.
Key Facts
- Brand Name
- Dyanavel XR
- Generic Name
- amphetamine
- NDC Code (Product)
24478-102- Manufacturer
- NextWave Pharmaceuticals, Inc
- Strength
- 2.5 mg/mL
- Dosage Form
- SUSPENSION, EXTENDED RELEASE
- Route
- ORAL
- Marketing Status
- DEA Schedule
- Schedule II (Controlled)
- Application #
- NDA208147
- Drug Class
- Central Nervous System Stimulant [EPC]
- Marketing Start
- 10/01/2015
Recall History
No Recall HistoryFrequently Asked Questions
What is Dyanavel XR used for?
Dyanavel XR is an extended-release liquid suspension of amphetamine used to treat attention-deficit/hyperactivity disorder (ADHD) in patients who can take oral medication. As a central nervous system stimulant, it works by increasing attention and decreasing impulsivity and hyperactivity in people with ADHD.
Is Dyanavel XR a controlled substance?
Yes, Dyanavel XR is classified as CII under the DEA Controlled Substances Act.
What is the generic name for Dyanavel XR?
The generic name for Dyanavel XR is amphetamine. There are 12 other brand versions of amphetamine.
What is the NDC code for Dyanavel XR 2.5 mg/mL?
The NDC (National Drug Code) for Dyanavel XR 2.5 mg/mL is 24478-102, listed by NextWave Pharmaceuticals, Inc.
Other Amphetamine Brands
See all →- AMPHETAMINE SULFATE10 mg/172162-1088
- Amphetamine6.3 mg/10480-3316
- Amphetamine Sulfate5 mg/10406-1219
- Amphetamine Extended-Release15.7 mg/162542-025
- Amphetamine Sulfate5 mg/170010-040
- Adzenys XR-ODT6.3 mg/170165-010
- Adzenys XR-ODT9.4 mg/170165-015
- Adzenys XR-ODT18.8 mg/170165-030
- Amphetamine Sulfate5 mg/142806-029
- Amphetamine Sulfate10 mg/142806-030
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)